 | Lance Stewart, Ph.D., M.B.A.
Chief Executive Officer, Emerald BioStructures "Emerald BioStructures has a world class team of researchers with expertise in gene-to-structure and structure-based drug design. We challenge ourselves to push the envelope on difficult projects and will develop technologies to address various targets." (more...) |  | Alex Burgin, Ph.D.
Chief Operating Officer, Emerald BioStructures "We are always emphasizing communication - working with our clients to understand the target and their ligands is the key to every successful collaboration." (more...) |  | Diana R. Wetmore, Ph.D.
Vice President of Business Development & Alliances, Emerald BioStructures “Emerald BioStructures leads the field in high throughput protein structure determination. Our combination of award-winning instrumentation and technical expertise makes us the leading CRO for fast and cost efficient service.” (more...) |  | Doug R. Davies, Ph.D.
Senior Director of Structural Biology, Emerald BioStructures "One of the keys to our success across dozens of projects is our collaborative approach. At Emerald BioStructures we strive to provide clear communication and facilitate an ongoing scientific dialog with our clients. We believe this culture results in great science, not just great customer service." (more..) |  | Bart Staker, Ph.D.
Senior Director of Structural Biology, Emerald BioStructures "We have invested heavily in automation and workflow management allowing us to greatly increase the number of structures solved while shortening the delivery time." (more...) |  | Peter Nollert, Ph.D.
Director of Membrane Protein Technologies, Emerald BioStructures
"We are fond of simple innovative technologies, especially in the area of membrane protein crystallization. Our interests circle around G-protein coupled receptors, microfluidics, lipid materials and we are focused on developing and commercializing technologies for the life science marketplace." (more...) |
|
